On the recordApril 22, 2015
Yet, here we have an excise tax that stifles the development of new products that improve the quality of life for Americans.
Source
congress.govYet, here we have an excise tax that stifles the development of new products that improve the quality of life for Americans.
Toomey argues that the tax hinders innovation in the medical device industry.
Share
More from Pat Toomey
I think there is a case to be made that there should be a regulatory regime on disclosure requirements for an issuer.
I think that there are a number of ways that you can go about creating a regulatory regime to take account of that risk.